Large-Scale Plasma Proteomics Reveals Preclinical Biomarkers of Incident Severe Liver Disease.
The absence of robust biomarkers for early detection of severe liver disease (SLD) highlights the critical need for high-throughput proteomics-driven discovery. In this prospective cohort study, we aimed to identify plasma protein signatures associated with incident SLD and assess their clinical utility. Using the larg...